Difficulty: Medium
Average Score: 80%
Practice
Suxamethonium
Correct answer
D
Rationale
Rationale:
Suxamethonium, also known as succinylcholine, is a depolarizing neuromuscular blocking agent used for rapid muscle relaxation during anesthesia. The correct answer is D) Should not be administered to burn patients after 24 hours. This is because burn patients are at risk of developing hyperkalemia due to the release of potassium from damaged muscle cells, and the use of suxamethonium can further increase this risk by causing further potassium release.
Option A) Is a non-depolarizing neuromuscular blocking agent is incorrect because suxamethonium is a depolarizing agent, not non-depolarizing.
Option B) Is contraindicated in all eye operations is incorrect as suxamethonium is commonly used in eye surgeries due to its rapid onset and short duration of action.
Option C) Stimulates cardiac muscarinic receptors and autonomic ganglia is incorrect. Suxamethonium acts primarily at the neuromuscular junction and does not directly stimulate cardiac muscarinic receptors or autonomic ganglia.
Educational context:
Understanding the pharmacology of CNS stimulants like suxamethonium is crucial for healthcare providers, especially anesthesiologists and critical care nurses. Knowledge of contraindications, adverse effects, and special considerations is essential for safe and effective drug administration. In the case of burn patients, the potential for hyperkalemia with suxamethonium highlights the importance of individualizing drug therapy based on patient-specific factors.
Suxamethonium, also known as succinylcholine, is a depolarizing neuromuscular blocking agent used for rapid muscle relaxation during anesthesia. The correct answer is D) Should not be administered to burn patients after 24 hours. This is because burn patients are at risk of developing hyperkalemia due to the release of potassium from damaged muscle cells, and the use of suxamethonium can further increase this risk by causing further potassium release.
Option A) Is a non-depolarizing neuromuscular blocking agent is incorrect because suxamethonium is a depolarizing agent, not non-depolarizing.
Option B) Is contraindicated in all eye operations is incorrect as suxamethonium is commonly used in eye surgeries due to its rapid onset and short duration of action.
Option C) Stimulates cardiac muscarinic receptors and autonomic ganglia is incorrect. Suxamethonium acts primarily at the neuromuscular junction and does not directly stimulate cardiac muscarinic receptors or autonomic ganglia.
Educational context:
Understanding the pharmacology of CNS stimulants like suxamethonium is crucial for healthcare providers, especially anesthesiologists and critical care nurses. Knowledge of contraindications, adverse effects, and special considerations is essential for safe and effective drug administration. In the case of burn patients, the potential for hyperkalemia with suxamethonium highlights the importance of individualizing drug therapy based on patient-specific factors.